Article: ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration.

Article: Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. ...
PR Newswire;  February 7, 2006 ;     700+ words ... ... strength and a nonrefrigerated oral solution (1 mg/mL). The ABILIFY 2 mg tablet equips physicians with an additional dosage ... partial agonist.(ii) "The availability of the ABILIFY 2 mg tablet is important for physicians because it allows ...

Article: U.S. Food and Drug Administration Approves ABILIFY(R) ...
PR Newswire;  November 6, 2007 ;     700+ words ... ... assigned to receive one of two fixed doses of ABILIFY [10 mg/day (n=100) or 30 mg/day (n=102 ... completed the six-week study (84 percent of ABILIFY 10 mg, 82 percent of ABILIFY 30 mg and 90 percent of placebo-treated patients ...

Article: Study shows intramuscular delivery of Abilify improves ...
Drug Week;  June 11, 2004 ;     700+ words ... ... dosing. Aripiprazole (Abilify) 10 mg administered IM demonstrated ... written in the United States. Abilify is available in 5 mg, 10 mg, 15 mg, 20 mg and 30 mg tablets. Serious side effects ... antipsychotic medicine, including Abilify. A rare but potentially ...

Article: ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use ...
PR Newswire;  December 12, 2006 ;     700+ words ... ... measure PANSS EC, the recommended dosage of 9.75 mg of ABILIFY Injection was shown to be effective in controlling ... patients with schizophrenia who transitioned from ABILIFY Injection to ABILIFY 15 mg tablets, improvement was maintained. ABILIFY ...

Article: U.S. Food and Drug Administration Approves ABILIFY(R) ...
PR Newswire;  February 29, 2008 ;     700+ words ... ... randomly assigned to receive one of two fixed doses of ABILIFY [10 mg/day (n=98) or 30 mg/day (n=99)] or ... of patients completed the four-week study (ABILIFY 10 mg: 86%; ABILIFY 30 mg: 78%; placebo: 77%). There was a low ...

Article: U.S. Food and Drug Administration Approves ABILIFY(R) ...
Business Wire;  May 8, 2008 ;     700+ words ... ... starting and target dose of 15 mg daily for ABILIFY monotherapy in the treatment ... approval of the starting dose of 15 mg daily for ABILIFY is based on results from two ... to receive either adjunctive ABILIFY (15 mg/day or an increase to 30 mg ...

Article: New Data and Analyses Demonstrate ABILIFY(R) ...
PR Newswire;  May 5, 2004 ;     700+ words ... ... bipolar disorder." Study Evaluating ABILIFY Safety And Efficacy In Short ... demonstrated the efficacy and safety of ABILIFY 30 mg/day (doses could be reduced ... first stabilized with open-label ABILIFY (starting dose of 30 mg/day, with po